Diabetic Macular Edema (DME) Completed Phase 4 Trials for Triamcinolone (DB00620)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00737971Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular EdemaTreatment
NCT00682539Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular EdemaTreatment